Search

everythinglearnresearchcommunity

for

Search:↓

A substance called poly(I:C) increases a protein called carbonic anhydrase II in skin cells, which might help with skin defense and healing.

Stem cell vesicles reduced eczema symptoms in mice safely.

TSLP affects atopic dermatitis by increasing sebum and reducing fat through IL-4/IL-13 signaling.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Aging reduces skin cell renewal and defense against germs due to TGFbeta, but blocking TGFbeta could help restore these functions.

Vitiligo and alopecia areata may have similar causes despite their differences.

Asthma may increase the risk of alopecia areata.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Stress increases certain chemicals in the skin and nerves, which might worsen skin conditions.

Punica granatum leaf extract may help treat skin fibrosis by reducing inflammation and oxidative stress.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Dupilumab may cause hair loss, so patients should be monitored.

Increased PPARGC1α relates to hair thinning in common baldness.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Certain proteins, caspases-1 and -11, are important in the early development of skin inflammation in mice.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Leflunomide is more likely to help treat alopecia areata than cause it.

The meeting discussed vitamin D3's role in fighting tuberculosis, potential treatments for skin conditions like psoriasis, and hair follicle regeneration as a possible solution for hair loss.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Removing Ctip2 in skin cells causes skin inflammation similar to atopic dermatitis.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

A new microneedle patch effectively treats atopic dermatitis by reducing skin stress and restoring immune balance.